Evidence map›Paper›PMID 35713852›Full record

ReviewArchives of pharmacal research2022

Astragalus polysaccharide: a review of its immunomodulatory effect.

Chun-Xiao Li, Ying Liu, Yu-Zhen Zhang, Jing-Chun Li, Jiang Lai

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of pharmacal research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 142 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed, 5 pooled it
78.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 5 syntheses or guidelines pooled it, 276 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Synergistic antitumor effects ofFrontiers in pharmacology · 2025
    Pooled it
  6. Trial
  7. Article
  8. Review
  9. Review
  10. Article
  11. International journal of molecular sciences · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chun-Xiao LiDepartment of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Ying LiuDepartment of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yu-Zhen ZhangDepartment of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Jing-Chun LiDepartment of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. lijingchunhtcm@163.com.ORCID http://orcid.org/0000-0001-7895-4005
Jiang LaiDepartment of Anorectal Surgery, Third People's Hospital of Chengdu, Chengdu, China. laijianghtcm@163.com.
Chengdu University of Traditional Chinese Medicine · CNThird People's Hospital of Chengdu · CN

Funding

Sichuan Provincial Administration of Traditional Chinese Medicine 2018QN019
6 · The paper itself

Abstract

The Astragalus polysaccharide is an important bioactive component derived from the dry root of Astragalus membranaceus. This review aims to provide a comprehensive overview of the research progress on the immunomodulatory effect of Astragalus polysaccharide and provide valuable reference information. We review the immunomodulatory effect of Astragalus polysaccharide on central and peripheral immune organs, including bone marrow, thymus, lymph nodes, spleen, and mucosal tissues. Furthermore, the immunomodulatory effect of Astragalus polysaccharide on a variety of immune cells is summarized. Studies have shown that Astragalus polysaccharide can promote the activities of macrophages, natural killer cells, dendritic cells, T lymphocytes, B lymphocytes and microglia and induce the expression of a variety of cytokines and chemokines. The immunomodulatory effect of Astragalus polysaccharide makes it promising for the treatment of many diseases, including cancer, infection, type 1 diabetes, asthma, and autoimmune disease. Among them, the anticancer effect is the most prominent. In short, Astragalus polysaccharide is a valuable immunomodulatory medicine, but further high-quality studies are warranted to corroborate its clinical efficacy.

Indexed as

Astragalus propinquusPolysaccharidesCytokinesMacrophagesT-LymphocytesCytokinesPolysaccharidesAnticancerAstragalus polysaccharideImmune cellsImmune organsImmune regulation

Identifiers

PMID35713852
OpenAlexW4283075997

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.